Clinical trial • Phase I • Neurology
Clinical trial in Parkinson's disease
Phase I trial for Parkinson's disease. 68 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Parkinson's disease
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 28-04-2025
- First CTIS Authorization Date
- 13-06-2025
Trial design
Phase I trial across 1 site in Netherlands.
- Target Sample Size
- 68
- Trial Duration For Participant
- 365
Eligibility
Recruits 68 Vulnerable population not selected; trial includes healthy volunteers and patients; consent/assent handling not specified..
- Vulnerable Population
- Vulnerable population not selected; trial includes healthy volunteers and patients; consent/assent handling not specified.
Recruitment
- Planned Sample Size
- 68
- Recruitment Window Months
- 12
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 68
Netherlands
- Earliest CTIS Part Ii Submission Date
- 10-06-2025
- Latest Decision Or Authorization Date
- 11-03-2026
- Processing Time Days
- 274
- Number Of Sites
- 1
- Number Of Participants
- 68
Sites
- Site Name
- Centre for Human Drug Research
- Department Name
- Neurology
- Principal Investigator Name
- Philip Kremer
- Principal Investigator Email
- clintrials@chdr.nl
- Contact Person Name
- Philip Kremer
- Contact Person Email
- clintrials@chdr.nl
- Number Of Participants
- 68
Sponsor
Primary sponsor
- Full Name
- Teitur Trophics ApS
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Denmark
Related trials
Other published trials that may interest you.